FCH
QTTB icon

Freestone Capital Holdings’s Q32 Bio QTTB Stock Holding History

Freestone Capital Holdings’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28
Closed -$5.64K – 1164
2020
Q4 		$5.64K Hold
28
– – ﹤0.01% 972
2020
Q3 		$5.35K Buy
+28
New +$6.28K ﹤0.01% 867

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Freestone Capital Holdings's QTTB Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Q32 Bio (QTTB) in Q1 2021, closing a stake of 28 shares — an estimated $5.64K sold.

Freestone Capital Holdings first reported a position in QTTB in Q3 2020 and held it in 2 quarters. The position peaked at $5.64K in Q4 2020. 109 funds tracked by Wall St. Rank hold QTTB as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Q32 Bio position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 28 Q32 Bio shares in Q1 2021, an estimated $5.64K.
  • Freestone Capital Holdings first reported a position in Q32 Bio in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Q32 Bio position peaked at $5.64K in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.